CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geng, Y.
Right arrow Articles by Choubey, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geng, Y.
Right arrow Articles by Choubey, D.
Cell Growth & Differentiation Vol. 11, 475-483, September 2000
© 2000 American Association for Cancer Research


Articles

p202 Levels Are Negatively Regulated by Serum Growth Factors1

Yanbiao Geng, Sanjay D’Souza, Hong Xin, Scott Walter and Divaker Choubey2

Department of Radiation Oncology, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois 60153

Abstract

p202 is an IFN-inducible phosphoprotein (Mr 52,000) whose expression in transfected cells retards proliferation. Interestingly, the reduced levels of p202 in fibroblasts (in consequence of the expression of antisense to 202 RNA), under reduced serum conditions, increase the susceptibility of cells to apoptosis. To identify the functional role of p202 in cell growth regulation, we tested whether serum growth factor levels in the culture medium affect p202 levels. Here we report that, under reduced serum conditions, the p202 levels were increased in fibroblasts, and the increase was seen at both the mRNA and protein levels. Moreover, an increase in p202 levels was correlated with cell growth arrest in the G1 phase of the cell cycle. Interestingly, the presence of platelet-derived growth factor AB, basic fibroblast growth factor, or transforming growth factor ß1 in the culture medium abrogated the increase in p202 levels seen under reduced serum conditions. We found that the increase in p202 levels was accompanied by an increase in JunD/activation protein 1 (AP-1) levels, and transfection of a JunD-encoding plasmid along with a reporter plasmid in which transcription of the reporter gene (luciferase) was driven by the 5'-regulatory region of the 202 gene resulted in an increase in the activity of luciferase. Additionally, stable overexpression of JunD in cells, under reduced serum conditions, also resulted in an increase in p202 levels. Interestingly, one of the AP-1-like DNA-binding sequences present in the 5'-regulatory region of the 202 gene could selectively bind to the JunD/AP-1 transcription factor. Taken together, our observations reported herein suggest that in fibroblasts, under reduced serum conditions, the increased levels of JunD/AP-1 contribute to the transcriptional up-regulation of p202 levels, which may be important for the regulation of apoptosis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Panchanathan, H. Xin, and D. Choubey
Disruption of Mutually Negative Regulatory Feedback Loop between Interferon-Inducible p202 Protein and the E2F Family of Transcription Factors in Lupus-Prone Mice
J. Immunol., May 1, 2008; 180(9): 5927 - 5934.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
F. Alimirah, J. Chen, F. J. Davis, and D. Choubey
IFI16 in Human Prostate Cancer
Mol. Cancer Res., March 1, 2007; 5(3): 251 - 259.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Fahrig, J.-C. Heinrich, B. Nickel, F. Wilfert, C. Leisser, G. Krupitza, C. Praha, D. Sonntag, B. Fiedler, H. Scherthan, et al.
Inhibition of Induced Chemoresistance by Cotreatment with (E)-5-(2-Bromovinyl)-2'-Deoxyuridine (RP101)
Cancer Res., September 15, 2003; 63(18): 5745 - 5753.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
X.-Y. Ma, H. Wang, B. Ding, H. Zhong, S. Ghosh, and P. Lengyel
The Interferon-inducible p202a Protein Modulates NF-{kappa}B Activity by Inhibiting the Binding to DNA of p50/p65 Heterodimers and p65 Homodimers While Enhancing the Binding of p50 Homodimers
J. Biol. Chem., June 13, 2003; 278(25): 23008 - 23019.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C.-j. Liu, B. Ding, H. Wang, and P. Lengyel
The MyoD-Inducible p204 Protein Overcomes the Inhibition of Myoblast Differentiation by Id Proteins
Mol. Cell. Biol., May 1, 2002; 22(9): 2893 - 2905.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2000 by the American Association of Cancer Research.